NICE confirms its role in new NHS after government U turnBMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d4525 (Published 18 July 2011) Cite this as: BMJ 2011;343:d4525
- Anne Gulland
A month after the government backtracked on its plans to downgrade the role of the UK National Institute for Health and Clinical Excellence (NICE), its chief executive has emphasised the value of the organisation.
Speaking at a Science Media Centre meeting to discuss the future work of NICE, Andrew Dillon sent out a clear message about the role of his organisation. “We want to make it very clear that we feel very strongly about the value of what we do,” he said.
In June the government made a U turn on its decision to give clinical commissioning groups (previously called commissioning consortiums) the power to decide which drugs would be …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial